Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Sarcoma 14Brain Neoplasms 9Gliosarcoma 8Glioblastoma 8Osteosarcoma 4Leiomyosarcoma 3Hemangiosarcoma 3Sarcoma, Synovial 2Rhabdomyosarcoma 2Neurofibrosarcoma 2Gastrointestinal Stromal Tumors 2Sarcoma, Myeloid 1Sarcoma, Kaposi 1Recurrent Uterine Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Mesothelioma 1Lung Neoplasms 1Liposarcoma 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Histiocytoma, Malignant Fibrous 1Hemangiopericytoma, Malignant 1Head and Neck Neoplasms 1Glioma 1Desmoid Tumors 1Colorectal Neoplasms 1

Interventions

pembrolizumab 5Gemcitabine 5Cisplatin 5Carboplatin 5Fluorouracil 4Filgrastim 4Cetuximab 3fludarabine 2cemiplimab 2belinostat 2atezolizumab 2Temozolomide 2Riluzole 2Peripheral Blood Stem Cell Transplantation 2Oncolytic Virotherapy 2Nivolumab 2Ipilimumab 2Cyclophosphamide 2Bortezomib 2AH 111585 2zanidatamab 1vocimagene amiretrorepvec 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1toripalimab 1spartalizumab 1seribantumab 1selpercatinib 1repotrectinib 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Sorafenib × Sarcoma × Clear all
NCT00703638 2017-11-29

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Completed
16 enrolled
BreastGastrointestinalGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Mesothelioma, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡